Harwood Charles C Jr - Net Worth and Insider Trading

Harwood Charles C Jr Net Worth

The estimated net worth of Harwood Charles C Jr is at least $584,958 dollars as of 2024-09-20. Harwood Charles C Jr is the Director of Syneos Health Inc and owns about 13,610 shares of Syneos Health Inc (SYNH) stock worth over $584,958. Details can be seen in Harwood Charles C Jr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Harwood Charles C Jr has not made any transactions after 2014-11-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Harwood Charles C Jr

Harwood Charles C Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Harwood Charles C Jr owns 4 companies in total, including Organogenesis Holdings Inc (ORGO) , Syneos Health Inc (SYNH) , and Avista Public Acquisition Corp II (AHPA) among others .

Click here to see the complete history of Harwood Charles C Jr’s form 4 insider trades.

Insider Ownership Summary of Harwood Charles C Jr

Ticker	Comapny	Transaction Date	Type of Owner
ORGO	Organogenesis Holdings Inc	2018-08-17	director
SYNH	Syneos Health Inc	2014-11-06	director
AHPA	Avista Public Acquisition Corp II	2022-08-24	director
		2022-08-24	director

Harwood Charles C Jr Latest Holdings Summary

Harwood Charles C Jr currently owns a total of 1 stock. Harwood Charles C Jr owns 13,610 shares of Syneos Health Inc (SYNH) as of November 6, 2014, with a value of $584,958.

Latest Holdings of Harwood Charles C Jr

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SYNH	Syneos Health Inc	2014-11-06	13,610	42.98	584,958

Holding Weightings of Harwood Charles C Jr

Harwood Charles C Jr Form 4 Trading Tracker

According to the SEC Form 4 filings, Harwood Charles C Jr has made a total of 0 transactions in Syneos Health Inc (SYNH) over the past 5 years. The most-recent trade in Syneos Health Inc is the sale of 0 shares on November 6, 2014, which brought Harwood Charles C Jr around $0.

Insider Trading History of Harwood Charles C Jr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Harwood Charles C Jr Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Harwood Charles C Jr Ownership Network

Ownership Network List of Harwood Charles C Jr

No Data

Ownership Network Relation of Harwood Charles C Jr

Harwood Charles C Jr Owned Company Details

What does Organogenesis Holdings Inc do?

Who are the key executives at Organogenesis Holdings Inc?

Harwood Charles C Jr is the director of Organogenesis Holdings Inc. Other key executives at Organogenesis Holdings Inc include 10 percent owner Albert Erani , 10 percent owner Michael W Katz , and director & President and CEO Gary S. Gillheeney .

Organogenesis Holdings Inc (ORGO) Insider Trades Summary

Over the past 18 months, Harwood Charles C Jr made no insider transaction in Organogenesis Holdings Inc (ORGO). Other recent insider transactions involving Organogenesis Holdings Inc (ORGO) include a net sale of 481,786 shares made by Albert Erani ,

In summary, during the past 3 months, insiders sold 0 shares of Organogenesis Holdings Inc (ORGO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 481,786 shares of Organogenesis Holdings Inc (ORGO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 481,786 shares.

Organogenesis Holdings Inc (ORGO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Organogenesis Holdings Inc Insider Transactions

No Available Data

What does Syneos Health Inc do?

Who are the key executives at Syneos Health Inc?

Harwood Charles C Jr is the director of Syneos Health Inc. Other key executives at Syneos Health Inc include Chief Financial Officer Michael J. Bonello , See remarks Stanford Rudnick , and Chief Business Officer Christian Tucat .

Syneos Health Inc (SYNH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Syneos Health Inc (SYNH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Syneos Health Inc (SYNH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Syneos Health Inc (SYNH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Syneos Health Inc Insider Transactions

No Available Data

What does Avista Public Acquisition Corp II do?

Who are the key executives at Avista Public Acquisition Corp II?

Harwood Charles C Jr is the director of Avista Public Acquisition Corp II. Other key executives at Avista Public Acquisition Corp II include director & 10 percent owner David F Burgstahler , director & 10 percent owner Thompson Dean , and director & 10 percent owner Avista Acquisition Gp Llc Ii .

Avista Public Acquisition Corp II (AHPA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Avista Public Acquisition Corp II (AHPA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avista Public Acquisition Corp II (AHPA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Avista Public Acquisition Corp II (AHPA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avista Public Acquisition Corp II Insider Transactions

No Available Data

What does OmniAb Inc do?

Who are the key executives at OmniAb Inc?

Harwood Charles C Jr is the director of OmniAb Inc. Other key executives at OmniAb Inc include director & President & CEO Matthew W Foehr , EVP & Finance and CFO Kurt A Gustafson , and See Remarks Charles S Berkman .

OmniAb Inc (OABI) Insider Trades Summary

Over the past 18 months, Harwood Charles C Jr made no insider transaction in OmniAb Inc (OABI). Other recent insider transactions involving OmniAb Inc (OABI) include a net purchase of 1,360,000 shares made by Matthew W Foehr , a net sale of 60,000 shares made by John L Higgins , and a net sale of 18,803 shares made by Kurt A Gustafson .

In summary, during the past 3 months, insiders sold 0 shares of OmniAb Inc (OABI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 85,757 shares of OmniAb Inc (OABI) were sold and 1,360,000 shares were bought by its insiders, resulting in a net purchase of 1,274,243 shares.

OmniAb Inc (OABI)'s detailed insider trading history can be found in Insider Trading Tracker table.

OmniAb Inc Insider Transactions

No Available Data

Harwood Charles C Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Harwood Charles C Jr. You might contact Harwood Charles C Jr via mailing address: C/o Inc Research Holdings, Inc., 3201 Beechleaf Court, Suite 600, Raleigh Nc 27604.

Discussions on Harwood Charles C Jr

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.